Clinical trial
Hepatotoxicity of Antituberculosis Therapy in a Real-World Setting: an Observational Study in China
NCT04159441 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepatotoxicity of Antituberculosis Therapy in a Real-World Setting: an Observational Study in China
- Lead sponsor
- Huashan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 5, 2019
- Completion date
- June 5, 2021
- Enrollment
- 5,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.